News about handicap and chronic illness

Remyelination therapies on trial

Monday, January 6. 2020

pixabay.com

News on one of the first trials looking at remyelination as a treatment for MS. See the results of a phase 2 clinical trial testing the safety and efficacy of opicinumab.

Read the article